Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) HKSE
1.15
+0.05(+4.55%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.15
+0.05(+4.55%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2667
First IPO Date
October 28, 2010
| Name | Title | Pay | Year Born |
| Guili Miao | Deputy Chief Executive Officer, Chief Investment Officer, Chief Financial Officer & Executive Director | 2.97M | 1974 |
| Weicheng Guo | Deputy Chairman & Chief Executive Officer | 3.46M | 1964 |
| Jionglong Zhang | Executive Director | 755,811 | 1962 |
| Yanling Chen | Joint Company Secretary & Executive Director | 2.08M | 1978 |
| Xianhui Meng | Deputy General Manager | 4.91M | 1964 |
| Fengsheng Che | Co-Founder & Executive Chairman | 8.07M | 1962 |
| Kin Wai Li | Joint Company Secretary | 0 | 1989 |
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.